ParagonRx Release: Complimentary REMS Webinar Discusses Improving Benefit-Risk Decisions for Medications
8/8/2011 9:55:48 AM
NEWARK, Del.--(BUSINESS WIRE)--FDA and the pharmaceutical industry each evaluate the benefits and risks of medications to determine whether the benefits outweigh the risks. With the increasing complexity of healthcare information, there is a growing need for better knowledge management and enhanced decision making when evaluating the benefits and risks of medications. This topic will be addressed in a complimentary webinar, “Evolving Towards More Systematic Benefit-Risk Assessments of Medications” which will take place this Wednesday, August 10th, at 12 noon EDT. This webinar is the latest in a series of monthly “Wednesday FoREMS” webinars sponsored by ParagonRx, an inVentiv Health company, and the only company specializing in pharmaceutical benefit-risk management and REMS.
comments powered by